Sale!

Liquid Biopsy Lung Cancer Test

6,000 د.إ

-25%

The “Liquid Biopsy Lung Cancer Test” is an advanced, non-invasive diagnostic approach offered by DNA Labs UAE, designed to detect and monitor lung cancer using a simple blood sample. Unlike traditional biopsy methods that require tissue samples, this cutting-edge technology analyzes circulating tumor DNA (ctDNA) in the bloodstream to identify genetic mutations and alterations associated with lung cancer. This method provides a quicker, less painful, and more convenient option for patients, potentially leading to early detection and personalized treatment strategies. The test is priced at 6000 AED, reflecting its sophisticated technology and the invaluable insights it offers into the genetic profile of lung cancer, aiding in the optimization of treatment plans and monitoring of disease progression.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Liquid Biopsy Lung Cancer Test

Cost: 6000.0 AED

Test Components

Streck Tube

Sample Condition

Blood

Report Delivery

21 Working Days

Method

NGS (Next-Generation Sequencing)

Test Type

Genetics

Doctor

General Physician

Test Department

Genetic Lab

Pre Test Information

This test requires a biopsy sample.

Test Details

Liquid biopsy is a non-invasive diagnostic test used to detect lung cancer by analyzing a sample of blood. The test is based on the detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) released by tumor cells into the bloodstream. CTCs are cancer cells that have detached from the primary tumor and entered the bloodstream, while cfDNA is DNA that is released into the bloodstream by dying cancer cells. These biomarkers can be detected and analyzed using advanced molecular techniques to identify specific genetic mutations or alterations that are associated with lung cancer.

The liquid biopsy test can be used to monitor the progression of lung cancer, detect early relapse, and guide treatment decisions. It is less invasive than traditional biopsy methods and can be performed more frequently, allowing for more precise monitoring of the disease. The liquid biopsy test has shown promising results in clinical trials and is expected to become an important tool in the diagnosis and management of lung cancer.

Test Name Liquid Biopsy Lung Cancer Test
Components Streck Tube
Price 6000.0 AED
Sample Condition Blood
Report Delivery 21 Working Days
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Require Biopsy Sample for this test
Test Details

Liquid biopsy is a non-invasive diagnostic test used to detect lung cancer by analyzing a sample of blood. The test is based on the detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) released by tumor cells into the bloodstream.

CTCs are cancer cells that have detached from the primary tumor and entered the bloodstream, while cfDNA is DNA that is released into the bloodstream by dying cancer cells. These biomarkers can be detected and analyzed using advanced molecular techniques to identify specific genetic mutations or alterations that are associated with lung cancer.

The liquid biopsy test can be used to monitor the progression of lung cancer, detect early relapse, and guide treatment decisions. It is less invasive than traditional biopsy methods and can be performed more frequently, allowing for more precise monitoring of the disease.

The liquid biopsy test has shown promising results in clinical trials and is expected to become an important tool in the diagnosis and management of lung cancer.